99 research outputs found

    Yunnantettix elytratus Storozhenko & Pushkar 2015, comb. n.

    No full text
    Yunnantettix elytratus (Günther, 1939), comb. n., fig. 18–20 Epitettix elytratus Günther, 1939: 306, fig. 233, 234; Shishodia, 1991: 14, plate 3, fig. 2–4; Blackith, 1992: 49; Otte, 1997: 20. N o t e s. This species was described based on a single female from India (East Himalayas [= West Bengal], Darjeeling district, Kalimpong, 200–1500 m, 04–05.1915) (Günther, 1939). Material is deposited in NZC (not studied). The holotype was redescribed and illustrated by Shishodia (1991). Males are unknown. By the presence of the narrow tegmen, the bisinuate hind margin of the lateral lobe of the pronotum (not only the lower sinus is present but also the shallow upper tegminal sinus), and the rugose disc of the pronotum, this species is similar to Yunnantettix bannaensis and transferred herein from Epitettix to Yunnantettix (see also Comparison, above). M e a s u r e m e n t s (after Günther, 1939 and Shishodia, 1991). Length: body: ♀ 11.0; pronotum: ♀ 10.0; hind femur: ♀ 5.5; ovipositor 1.3. D i s t r i b u t i o n. India (West Bengal).Published as part of Storozhenko, S. Yu. & Pushkar, T. I., 2015, Taxonomic Review Of The Genus Yunnantettix (Orthoptera, Tetrigidae) From The Oriental Region, pp. 211-218 in Vestnik Zoologii 49 (3) on page 217, DOI: 10.1515/vzoo-2015-0023, http://zenodo.org/record/645235

    Assessment of the psychological status of urologists during the COVID-19 pandemic

    No full text
    The aim of this study was to analyze the symptoms of depression, anxiety, and stress in urologists during the COVID-19 pandemic. MATERIALS AND METHODS: 90 urologists aged 25 to 60 years (M=37.27, S.D.=9.53), 93% of them were men, participated in the online survey. They answered questions about their attitude to their job as doctors and the impact of COVID-19. They filled out the Depression, Anxiety and Stress Scales (DASS-21), the Ten Item Personality Inventory (TIPI) and answered questions assessing their sense of control. RESULTS: The greatest concern among urologists is the risk of getting infected with COVID-19 (for 30% of the doctors). 43% of urologists state that their profession interesting. A positive attitude to work, as well as the Big Five traits (Conscientiousness, Emotional Stability and Agreeableness) are associated with lower levels of depression, anxiety, stress and lack of control. Working with COVID-19 patients reduces stress and increases the sense of control. Age and high levels of Emotional Stability predicted lower levels of anxiety, depression and stress. DISCUSSION: Working with COVID-19 patients allows doctors to feel more control over what is happening. A sense of control, in turn, and a positive attitude towards work are associated with a lower levels of depression, anxiety and stresssymptoms. CONCLUSION: The results of this study can be used in selection of therapeutic targets for psychotherapy, administered to doctors; in prevention of symptoms of anxiety, stress and depression among doctors; and in professional selection of doctors for working in crisis situations

    Composition of bottom sediments from the Clarion Fracture Zone

    No full text
    New data on lithology and stratigraphy of Cenozoic sediments from the Clarion Transform Fault Zone (Pacific Ocean) have been obtained on the base of polygon studies. It has been established that on different blocks (uplifted and subsided) of the Clarion tectonic structure deposits of different age (Eocene to Quaternary) occur. Unconsolidated sediments have been deposited under pelagic conditions since Eocene (probably, since Early Cretaceous) until now. Their mineral composition and content of different ore components are given

    ORGANIZATION OF MEDICAL CARE FOR ELDERLY PATIENTS UNDER THE CONDITIONS OF THE COVID-19 PANDEMIC

    No full text
    The first report of the new coronavirus infection (COVID-19) appeared at the end of December 2019 and in March,2020 the World Health Organization announced COVID-19 a pandemic. The steady number of newly detected cases increase predetermined the modernization of the global healthcare system, shifting the paradigm of fighting with the COVID-19 pandemic towards maximum resource conservation. The change in the medical care provision for infectious patient's approach led first to a gradual decrease, and then to a complete cessation of planned surgical treatment, outpatient examinations, as well as observation of high-risk patients, which primarily include elderly patients. As a result of this, the key objective of this systematic review was to analyze sources of existing practice of providing urological care to patients of the older age group in the context of the COVID-19 pandemic. In accordance with the search for the keywords, the study reflects world and its own experience of MSMSU Urology Department in the treatment of age-related patients in the current epidemiological situation. The analysis showed that infectious complications from the urinary system take a leading position among the common complications inherent in elderly patients with COVID-19. The development of catheter-associated infection, the occurrence of antibiotic-resistant forms of bacteria, asymptomatic bacteriuria are only a small part of the problems clinicians have to face in newly profiled departments

    Organization of Urological and Oncourological Care for Patients in a Pandemic of COVID-19: Overcoming Existing Limitations

    No full text
    The new coronavirus infection pandemic has certainly changed all spheres of human activity, the healthcare system was completely transformed and reassignment in a short time The built model of a personalized approach to each patient was replaced by the provision of health services to groups of patients with similar symptoms of the disease and severity, and conditions not associated with coronavirus infection, anyway, took a back seat Since the announcement of the COVID-19 pandemic, the main human and material resources have been directed at combating the new infection To date, almost every country has cases of coronavirus infection The planned surgical care was temporarily stopped, what could not but affect the outcomes of diseases A special category of patients is represented by patients with diagnosed malignant neoplasms, the delay in treatment of which can significantly reduce the life expectancy and/or quality of life The current state of the problem served as a catalyst for the development of telemedicine technologies, which simplified communication in the patient-physician and physician-physician relationship Urinary tract infections are one of the most common reasons for visiting a urologist, which implies the prescription of antibacterial drugs However, in a pandemic, remote prescription of these drugs is limited by the lack of face-to-face specialist consultations This enabled make it possible to use drugs based on bacteriophages Patient management problems were solved by using distance counseling techniques In this article we present an algorithm for providing urological and oncourological care to patients in the context of the COVID-19 pandemic, as well as an overview of the existing world practice in the implementation of telemedicine consultations in the current epidemiological situation Пандемия новой коронавирусной инфекции, безусловно, изменила многие сферы деятельности человека, причем в первую очередь в течение короткого времени была полностью преобразована и перепрофилирована система здравоохранения Выстроенную модель персонифицированного подхода к каждому пациенту заменило оказание медицинской помощи группам больных со схожими симптомами заболевания и тяжестью течения, а патологии, не связанные с коронавирусной инфекцией, так или иначе отошли на второй план С момента объявления пандемии COVID-19 основные человеческие и материальные ресурсы были направлены на борьбу с новой инфекцией Во многих странах временно прекращено оказание плановой хирургической помощи, что не могло не сказаться на исходах тех или иных заболеваний Отдельную категорию представляют пациенты с выявленными злокачественными новообразованиями, промедление лечения которых может существенно снизить продолжительность и/или качество их жизни Современное состояние проблемы послужило катализатором для развития телемедицинских технологий, что упростило коммуникацию в отношениях пациент-врач и врач-врач Инфекции мочевыводящих путей являются одной из наиболее частых причин обращения к врачу-урологу, что подразумевает назначение антибактериальных препаратов Однако в условиях пандемии дистанционно назначение данных лекарственных средств ограничено отсутствием очных консультаций специалиста Это позволило в большей степени применять препараты на основе бактериофагов Проблемы курации пациентов были решены с помощью методик дистанционного консультирования В данной статье представлены алгоритм оказания урологической и онкоурологической помощи пациентам в условиях пандемии COVID-19, а также обзор существующей мировой практики по реализации телемедицинских консультаций в настоящей эпидемиологической обстановк

    Acute kidney injury in COVID-19: clinical and morphological comparisons based on autopsy data

    No full text
    Severe Acute Respiratory Syndrome (SARS-CoV-2) has spread rapidly throughout the world, causing high morbidity and mortality. Analysis of clinical and autopsy data may allow to understand this disease. The results of pulmonary and renal autopsies in 37 deceased patients from COVID-19 are presented. MATERIALS AND METHODS: An autopsy was performed in Moscow in 37 deceased patients aged from 28 to 94 years. The microscopic features of the lungs and kidneys were examined using hematoxylin and eosin staining. RESULTS: Important findings include diffuse alveolar injury, pulmonary thrombosis and microangiopathy, as well as acute kidney injury in all cases, varying in severity. CONCLUSIONS: We report the presence of acute kidney injury in all cases, which requires correction of renal function in patients with SARS-CoV-2, with control of serum creatinine levels, urine volume, proteinuria and hematuria

    Characteristics of covid-19 and possibilities of early causal therapy. Results of favipiravir use in clinical practice

    No full text
    Objective. Тo evaluate the efficacy and safety of favipiravir (Areplivir) in patients with coronavirus disease 2019 (COVID-19) and compare it with recommended standard therapy. Patients and methods. Two hundred men and women aged between 18 and 80 years with COVID-19 were randomized into this study. The experimental group included patients who received favipiravir, whereas the control group comprised patients who received causal therapy in accordance with the latest version of the temporary methodical recommendations of the Ministry of Health of Russia ‘Prevention, diagnosis, and treatment of coronavirus infection (COVID-19).’ The efficacy and safety of therapy were evaluated by assessing clinical improvement using the WHO Ordinal Scale for Clinical Improvement, clinical and laboratory parameters, findings of chest computed tomography (CT), and elimination of SARS-CoV-2. We also analyzed the frequency and type of adverse events, need for invasive and non-invasive ventilation, and death rates. Results. Our analysis has demonstrated significant benefits of favipiravir over standard therapy in terms of the time to clinical improvement (in the experimental group it was 4 days shorter on average), time to recovery, frequency of recovery after 10 days (44% of patients from the experimental group and 10% of patients from the control group had no clinical signs of the disease at this time-point), and frequency of virus elimination by day 10 of therapy. Treatment with favipiravir was associated with a significant improvement in the lung condition (according to CT), normalization of laboratory parameters, and saturation level. Favipiravir has demonstrated a good safety profile similar to that of standard therapy. There was no difference in the frequency of adverse events between the experimental and control groups. Conclusion. The use of favipiravir for the treatment of SARS-CoV-2 infection reduced the time to clinical improvement by 4 days on average compared to standard therapy, ensured improvement of the lung condition (according to CT scans), and facilitated virus elimination in more than 90% of patients, thereby promoting faster recovery. Favipiravir had a good safety profile and was well tolerated by patients. This treatment regimen was shown to be effective, sufficient, and clinically reasonable to achieve good outcomes. Timely initiation of therapy with favipiravir (Areplivir) improves disease prognosis and reduces the global socioeconomic burden of the current pandemic
    corecore